Table 3 Overall associations between QoL at baseline (AFEQT) and the improvement in symptom scores (EHRA improvement) after 12 months (T1)
From: The prognostic value of quality of life in atrial fibrillation on patient value
|  | Total study population |  | EHRA improvement (T1-T0) | ||
|---|---|---|---|---|---|
AFEQT score (T0) | n (%) | n (%) | ORminimally−adjusted (95% CI) | ORmv−adjusted (95% CI) | p-value |
First quartile (4.63 to ≤ 57.41) | 121 (28.0%) | 69 (57.0%) | 4.41 (2.41–8.08) | 4.55 (2.45–8.44) | < 0.001 |
Second quartile (> 57.41 to ≤ 75.93) | 97 (22.5%) | 50 (51.5%) | 3.53 (1.88–6.62) | 3.42 (1.80–6.53) | < 0.001 |
Third quartile (> 75.93 to ≤ 90.74) | 116 (26.9%) | 49 (42.2%) | 2.44 (1.33–4.48) | 2.34 (1.26–4.34) | 0.007 |
Fourth quartile (> 90.74 to 100) | 98 (22.7%) | 22 (22.4%) | 1 (ref.) | 1 (ref.) |  |